Fiagon
- Company typePrivate
- Founded2007
- HeadquartersHennigsdorf, Germany
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Fiagon firmographics
Firmographics- Name
- Fiagon
- Legal name
- Fiagon GmbH
- Website
- https://fiagon.de
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Fiagon industry classification
Industry- Product category
- Surgical Navigation Systems (Medical Devices - ENT)
- NAICS
- Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing (334511), Surgical and Medical Instrument Manufacturing (339112), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Search, Detection, Navagation, Guidance, Aeronautical Sys (3812), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT) (HLAHADAG)
- akta.pro secondary industries
- General Otolaryngology (ENT) (HLAKAMAA), Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB), ENT / Otolaryngology Surgery Centers (HLAFAIAJ)
Keywords
Where Fiagon is headquartered
LocationHeadquarters
- HQ city
- Hennigsdorf
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Fiagon business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Medical Device Sales: Sale of surgical navigation hardware systems and related medical devices for ENT procedures
- Service & Support: Technical support and maintenance services for navigation systems
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Fiagon product offering
Product offeringCore offering
Fiagon develops and sells electromagnetic clinical navigation systems for ear, nose, and throat (ENT) surgery, anchored by its ENT Series product line and flagship 4D Navigated Sinuplasty™ technology. The hardware systems provide real-time, three-dimensional tracking guidance for endoscopic sinus and in-office sinuplasty procedures. The company also offers technical service and support for installed navigation platforms.
Product overview
Fiagon offers a surgical navigation product portfolio centered on the ENT Series as its core product line. The flagship technology includes 4D Navigated Sinuplasty™ which represents their advanced navigation capability for sinus surgery procedures. The company was acquired by Hemostasis LLC in 2022, marking a strategic consolidation in the medical technology space.
Differentiator
Problem solved
Functional benefit
Products and services
- ENT Series Fiagon's core surgical navigation product line designed for Ear, Nose, and Throat (ENT) surgical procedures, providing precision electromagnetic navigation capabilities for endoscopic sinus surgery and other ENT interventions. Targeted at ENT surgeons and healthcare facilities performing these procedures.
- Service & Support Technical support and maintenance services for Fiagon's installed surgical navigation systems, provided to hospitals, ambulatory surgery centers, and ENT practices using the navigation hardware.
Companies that use Fiagon
Customer profileSegments2 records
Ideal customer profiles1 record
Fiagon technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Fiagon partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- HemostasiscoreHemostasis LLC completed the acquisition of Fiagon Medical Technologies in May 2022. This represents a significant ownership change where Hemostasis gained control of Fiagon's surgical navigation technology business.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Fiagon competitors and assessment
Company assessmentDirect peers
- Brainlab: Brainlab is a direct peer offering surgical navigation and intraoperative guidance platforms across multiple specialties including ENT. It competes head-to-head with Fiagon in electromagnetic and image-guided navigation for sinus and skull-base procedures, with a comparable business model centered on capital hardware and software.
- Acclarent (Johnson & Johnson MedTech): Acclarent is a direct peer in ENT navigation and balloon sinuplasty, now part of Johnson & Johnson. It addresses the same ENT surgeon customer base as Fiagon with navigation-assisted sinus surgery products, making it one of the closest specialty competitors.
Broad incumbents
- Medtronic: Medtronic operates the StealthStation surgical navigation system, a broad incumbent platform spanning neurosurgery, spine, and ENT. While not ENT-only, its installed base, capital bundles, and hospital relationships make it a key competitor for navigation procurement decisions that include Fiagon.
- Stryker: Stryker offers surgical navigation and computer-assisted surgery solutions across multiple specialties. As a broad incumbent with extensive OR capital equipment relationships, it competes with Fiagon for hospital and ASC navigation budgets at the enterprise level.
- Integra LifeSciences: Integra LifeSciences has a meaningful ENT and neurosurgery portfolio, including products used in sinus and skull-base procedures. It overlaps with Fiagon's customer base and surgical workflow, making it a relevant broad incumbent peer in the ENT navigation and instrumentation space.
- KARL STORZ: KARL STORZ is a leading endoscopy and visualization systems provider with strong presence in ENT. Its endoscopy hardware often integrates or co-sits with navigation platforms, making it an adjacent incumbent whose bundled solutions compete with Fiagon's integrated navigation proposition.
- Smith+Nephew: Smith+Nephew offers ENT and surgical navigation-adjacent products and serves ENT surgeons and hospitals globally. As a diversified medtech incumbent, it competes for the same ENT procedural budgets and capital equipment decisions that Fiagon targets.
- Olympus: Olympus is a broad incumbent in endoscopy and ENT visualization, with a global installed base in ENT and sinus surgery suites. Its visualization and scope products are commonly bundled in ENT ORs alongside navigation, positioning it as an indirect but influential competitor to Fiagon.
Emerging players
- Intersect ENT: Intersect ENT (now part of Medtronic) developed steroid-eluting sinus implants and ENT-focused therapeutic devices. It shares the ENT surgeon customer base with Fiagon and represents an emerging, specialty-focused player in the sinus surgery ecosystem.
Others
- Hemostasis LLC: Hemostasis LLC is Fiagon's parent company following the May 2022 acquisition. As the strategic owner, it shapes Fiagon's capital allocation, distribution strategy, and portfolio positioning, making it a directly relevant ecosystem participant for assessing Fiagon's strategic context.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Fiagon social profiles
Digital presenceFiagon financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fiagon leadership team
Management profileNumber of profiles
Profiles5 records
Fiagon funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fiagon M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fiagon
What does Fiagon do?
Fiagon develops and sells electromagnetic clinical navigation systems for ear, nose, and throat (ENT) surgery, anchored by its ENT Series product line and flagship 4D Navigated Sinuplasty™ technology. The hardware systems provide real-time, three-dimensional tracking guidance for endoscopic sinus and in-office sinuplasty procedures. The company also offers technical service and support for installed navigation platforms.
Is Fiagon a public or private company?
Fiagon is a private company. It is classified as corporate owned and is currently operating.
When was Fiagon founded?
Fiagon was founded in 2007. It employs 51 to 100 people.
Where is Fiagon based?
Fiagon is headquartered in Hennigsdorf, Germany, in the Europe region.
How does Fiagon make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are service & Support.
Who are Fiagon's main competitors?
Direct peers on record are Brainlab and Acclarent (Johnson & Johnson MedTech). Broad incumbents are Medtronic, Stryker, Integra LifeSciences, KARL STORZ, Smith+Nephew and Olympus. Intersect ENT is listed as an emerging player. Hemostasis LLC is listed as an others.
Does Fiagon have an API?
No public API is recorded for Fiagon.
What industry is Fiagon in?
Fiagon's product category is Surgical Navigation Systems (Medical Devices - ENT). Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAKAMAA, General Otolaryngology (ENT). Its NAICS code is 334511 and its SIC code is 3841.